Tracked deals
20
20 tracked deals across 2019-2026.
Paris, Île-de-France, France
Eurazeo is a global investment company and private markets asset manager investing in a diversified portfolio across private equity, private debt, real estate and infrastructure. It supports companies of all sizes and has offices across major markets worldwide; Eurazeo is listed on Euronext Paris.
Tracked deals
20
20 tracked deals across 2019-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
15 buyout · 2 addon · 2 growth capital
Last 8 years
Supporting Data
Showing the 12 most recent of 20 tracked deals for Eurazeo.
Ardian has entered into a definitive agreement to sell Netco Group, a European provider of critical maintenance services for conveyor systems, to Eurazeo. The deal includes reinvestment by Netco’s founding family and management, and remains subject to regulatory approvals and closing conditions.
Eurazeo's mid-large buyout team has entered exclusive negotiations to acquire a majority stake in Mapal from PSG Equity, with Mapal's management and employees investing alongside Eurazeo and PSG Equity retaining a minority stake. Mapal is a Madrid-headquartered, AI-powered hospitality SaaS provider serving thousands of customers and tens of thousands of venues; the investment will support Mapal's international growth and product development and is subject to customary approvals.
Oakley Capital Fund V has been granted exclusivity to acquire a co-controlling stake in French managed security services provider I-TRACING alongside Eurazeo, with Sagard NewGen reinvesting as a minority investor. CVC Credit is providing debt financing to support the transaction; the deal is subject to employee consultation and regulatory approvals. I-TRACING, founded in Paris in 2005, employs ~700 cybersecurity experts across multiple countries and will use the investment to pursue organic growth, M&A and hiring.
Eurazeo has signed an agreement to acquire the stake in French fintech Eres Group from IK Partners' IK VIII Fund; financial terms were not disclosed and the transaction is subject to regulatory approvals. Eres, headquartered in Paris, is a leading provider of employee profit-sharing, retirement schemes and asset management with approximately €6.7 billion in assets under management and a distribution network of over 6,600 distributors.
Triton Fund IV has sold a portfolio of four companies—Assemblin, EQOS Energie, Flokk and Unica—into a new vehicle, Triton IV Continuation Fund (TIV CF), which closed at €1.63 billion. The continuation fund was underwritten by HarbourVest Partners and LGT Capital Partners with anchor commitments from Eurazeo and Pantheon, and provides liquidity to Triton Fund IV investors while allowing rollovers into the new vehicle.
Oncodesign Services, majority-held by ERES IV SLP (Edmond de Rothschild Private Equity), has acquired Dutch fragment-based drug discovery specialist ZoBio to strengthen its upstream Drug Discovery capabilities. Concurrently, Nov Santé Actions Non Cotées (managed by Eurazeo) has invested in Oncodesign Services to support external growth and the group's international expansion.
Contentsquare closed a $600 million growth financing led by Sixth Street Growth — $400 million in Series F equity and $200 million in debt — bringing total funding to $1.4 billion and valuing the company at $5.6 billion. The capital will be used to accelerate product innovation, pursue M&A and expand the company's footprint in key markets.
Apax has signed an exclusivity agreement with Eurazeo to acquire a majority stake in Vitaprotech, a French provider of premium electronic security solutions for sensitive sites. The transaction is subject to applicable regulatory approvals, and the parties expect to use Apax’s support to accelerate Vitaprotech’s international development and buy-and-build strategy.
Smile Group has acquired Munich-based e‑commerce agency creativestyle GmbH, with the transaction supported by Smile's shareholders Keensight Capital and Eurazeo. The deal brings creativestyle's ~85 digital experts and Polish delivery capabilities into Smile's 2,000‑person open‑source digital platform to accelerate Smile's expansion into the German and German‑speaking markets and strengthen its e‑commerce offerings.
Eurazeo has acquired a majority stake in Cranial Technologies from BPOC, investing over $200 million alongside an equity rollover from management. Cranial Technologies is the market leader in custom cranial orthotics (the DOC Band) and operates approximately 80 U.S. clinics plus licensed international locations; the investment will support U.S. and international expansion and product-line extension.
Eurazeo has made a $75 million minority growth investment in Jaanuu, a direct-to-consumer designer and manufacturer of premium medical apparel, to support brand marketing, product innovation and international expansion. The funding brings Jaanuu's total capital raised to roughly $100 million and Eurazeo will join an expanded board to help guide the company’s next phase of global growth.
Funds advised by SK Capital Partners acquired a majority shareholding in SEQENS, investing alongside Bpifrance, Nov Santé, Mérieux Equity Partners, Ardian, Eximium and SEQENS' management. The deal includes the integration of Wavelength Pharmaceuticals into SEQENS and the prior divestiture of certain non-core mineral specialties assets; SEQENS emerges as a strengthened pharmaceutical CDMO with ~€1.1bn revenue and ~3,200 employees.
Turn tracked acquisition activity into an outreach-ready buyer list.